$0.9538
-0.02-1.67%
At close: -
$0.8835
-0.07-7.37%
After Hours: 5:28 PM EDT
Comments
Loading...
Artelo Biosciences Analyst Ratings and Price Targets | NASDAQ:ARTL | Benzinga
Artelo Biosciences Inc has a consensus price target of $19.25 based on the ratings of 4 analysts. The high is $60 issued by Ladenburg Thalmann on April 3, 2023. The low is $5 issued by HC Wainwright & Co. on March 4, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital, HC Wainwright & Co., and D. Boral Capital on April 2, 2025, March 4, 2025, and March 3, 2025, respectively. With an average price target of $5.67 between D. Boral Capital, HC Wainwright & Co., and D. Boral Capital, there's an implied 541.39% upside for Artelo Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
HC Wainwright & Co.
EF Hutton
Ladenburg Thalmann
1calculated from analyst ratings
Analyst Ratings for Artelo Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/02/2025 | Buy Now | 579.12% | D. Boral Capital | Jason Kolbert42% | $6 → $6 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 579.12% | D. Boral Capital | Jason Kolbert42% | $6 → $6 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 579.12% | D. Boral Capital | Jason Kolbert42% | $6 → $6 | Maintains | Buy | Get Alert |
| 01/14/2025 | Buy Now | 579.12% | D. Boral Capital | Jason Kolbert42% | $6 → $6 | Maintains | Buy | Get Alert |
| 12/09/2024 | Buy Now | 579.12% | D. Boral Capital | Jason Kolbert42% | $6 → $6 | Maintains | Buy | Get Alert |
| 12/09/2024 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 10/01/2024 | Buy Now | 579.12% | EF Hutton | Jason Kolbert42% | → $6 | Initiates | → Buy | Get Alert |
| 08/14/2024 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2024 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | $5 → $5 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | 465.93% | HC Wainwright & Co. | Vernon Bernardino49% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2023 | Buy Now | 6691.17% | Ladenburg Thalmann | Michael Higgins48% | → $60 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | 6125.24% | HC Wainwright & Co. | Vernon Bernardino49% | → $55 | Reiterates | → Buy | Get Alert |
| 08/12/2022 | Buy Now | 6125.24% | HC Wainwright & Co. | Vernon Bernardino49% | → $55 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Artelo Biosciences (ARTL) stock?
The latest price target for Artelo Biosciences (NASDAQ:ARTL) was reported by D. Boral Capital on April 2, 2025. The analyst firm set a price target for $6.00 expecting ARTL to rise to within 12 months (a possible 579.12% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Artelo Biosciences (ARTL)?
The latest analyst rating for Artelo Biosciences (NASDAQ:ARTL) was provided by D. Boral Capital, and Artelo Biosciences maintained their buy rating.
When was the last upgrade for Artelo Biosciences (ARTL)?
There is no last upgrade for Artelo Biosciences
When was the last downgrade for Artelo Biosciences (ARTL)?
There is no last downgrade for Artelo Biosciences.
When is the next analyst rating going to be posted or updated for Artelo Biosciences (ARTL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artelo Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artelo Biosciences was filed on April 2, 2025 so you should expect the next rating to be made available sometime around April 2, 2026.
Is the Analyst Rating Artelo Biosciences (ARTL) correct?
While ratings are subjective and will change, the latest Artelo Biosciences (ARTL) rating was a maintained with a price target of $6.00 to $6.00. The current price Artelo Biosciences (ARTL) is trading at is $0.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
